Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 8 of 8 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime | - | - | - | - | 1件: 161 161 💬1. (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Botulism Toxin Treatment | - | - | - | - | 1件: 161 161 💬2. Botulism Toxin Treatment
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Celecoxib | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬3. Celecoxib
| 1件: PTGS2 PTGS2 💬3. Celecoxib
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemi ... | 10件: 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 💬3. Celecoxib
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Doxycycline | 1件: Doxycycline Doxycycline | 2件: Doxycycline
Doxycycline
,Doxycycline 💬 4. Doxycycline
| - | - | 17件: 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 💬4. Doxycycline
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | LX3305 | - | - | - | - | 2件: 46 46, 161 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | LX3305 250 mg capsule | - | - | - | - | 1件: 161 161 💬6. LX3305 250 mg capsule
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | None | 1件: Interleukin-1 alpha, human recombinant Interleukin-1 alpha, human recombinant | - | - | - | 20件: 6 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337 💬7. None
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | SCENESSE | 1件: Afamelanotide Afamelanotide | 1件: Afamelanotide
Afamelanotide
💬8. SCENESSE
| 1件: MC1R MC1R 💬8. SCENESSE
| 2件: Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 3件: 159 159, 161, 254 💬
|